Skip to main content
Clinical Trials/NCT02747394
NCT02747394CompletedNot Applicable

Cognitive Training for Fragile X Syndrome

University of California, Davis2 sites in 1 country106 target enrollmentStarted: January 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
106
Locations
2
Primary Endpoint
Composite of Stanford Binet, Fifth Edition Block Span and Leiter-R Spatial Working Memory

Study Overview

Brief Summary

Individuals with fragile X syndrome (FXS) demonstrate profound executive function deficits that interfere with learning, socialization and emotion regulation. Extensive research focused on the animal models of FXS show that targeted pharmacological agents can normalize synaptic connectivity and reverse cognitive and behavioral deficits. This translational work has led to multiple national and international controlled trials in humans with FXS now underway. However, in contrast to the heavy focus on medication treatments, there have been no controlled trials to empirically-validate cognitive or behavioral interventions for FXS. The proposed study, the first non-pharmacological controlled trial for FXS, will evaluate the efficacy of Cogmed, a cognitive training program proven to enhance working memory and executive/frontal function in a variety of clinical populations. Demonstration of effective Cogmed training for FXS would represent a major advance in the field, one that may also generalize to other forms of intellectual disability. Furthermore, it is critical to determine whether the targeted pharmacological treatments can accelerate learning and cognitive development. Thus, the validation of Cogmed for FXS will provide a paradigm for testing hypotheses focused on combined efficacy of medication and cognitive training.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • fragile X full mutation
  • normal or corrected vision
  • English or Spanish speaking
  • ability to pass three-span items following completion of a Cogmed training session at baseline
  • parental agreement to maintain adherence to the training schedule and to not alter other treatments during the study unless medically necessary

Exclusion Criteria

  • previous Cogmed training
  • significant medical problems that would interfere with the study or significant brain trauma

Arms & Interventions

Adaptive Cogmed

Experimental

5 days per week for 5-6 weeks of parent aided visual working memory training, consisting of adaptive Cogmed

Intervention: Working Memory Training (Other)

Non-Adaptive Cogmed

Other

5 days per week for 5-6 weeks of parent aided visual working memory training, consisting of non-adaptive Cogmed

Intervention: Working Memory Training (Other)

Outcomes

Primary Outcomes

Composite of Stanford Binet, Fifth Edition Block Span and Leiter-R Spatial Working Memory

Time Frame: 5-6 weeks

Average of z scores obtained from Block Span and Leiter-R Spatial Working Memory

Secondary Outcomes

  • Wechsler Intelligence Scale for Children-IV Digit Span(3 month followup)
  • Kiddie Test of Attentional Performance (KiTAP)(3 month followup)
  • Behavior Rating Inventory Rating of Executive Function (BRIEF; Teacher and Caregiver Reports)(3 month followup)
  • Swanson, Nolan and Pelham (SNAP-IV)(3 month followup)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Cognitive Training for Fragile X Syndrome | Clinical Trial